LBRX · Lb Pharmaceuticals Inc · Documents
$39.23
-1.77 (-4.32%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$1.32B
Shares
32.26M
Volume · Oct 21
247.14K
Avg daily vol (3M)
390.85K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| S-3ASR | — | 2026-10-01 | — | |
| 8-K | — | 2026-09-15 | — | |
| 8-K | — | 2026-09-03 | — | |
| 8-K | — | 2026-08-11 | — | |
| 10-Q | — | 2026-08-11 | 2026-06-30 | |
| 8-K | — | 2026-07-29 | 2026-07-28 | |
| 8-K | — | 2026-07-22 | — | |
| Investor Event Transcript | — | 2026-06-16 | 2026-06-30 | |
| 8-K | — | 2026-06-10 | 2026-06-08 | |
| 8-K | — | 2026-06-09 | 2026-06-03 | |
| Investor Event Transcript | — | 2026-06-04 | 2026-06-30 | |
| 8-K | — | 2026-05-12 | — | |
| 10-Q | — | 2026-05-12 | 2026-03-31 | |
| DEF 14A | — | 2026-04-23 | 2026-06-03 | |
| ARS | — | 2026-04-23 | 2025-12-31 | |
| DEFA14A | — | 2026-04-23 | — | |
| S-1 | — | 2026-04-06 | — | |
| 10-K | — | 2026-03-26 | 2025-12-31 | |
| 8-K | — | 2026-03-26 | — | |
| 8-K | — | 2026-03-16 | 2026-03-13 | |
| 8-K | — | 2026-03-10 | 2026-03-04 | |
| 8-K | — | 2026-02-05 | 2026-02-04 | |
| 8-K | — | 2025-11-13 | 2025-11-10 | |
| 8-K | — | 2025-11-12 | — | |
| 10-Q | — | 2025-11-06 | 2025-09-30 | |
| 8-K | — | 2025-11-06 | — | |
| 8-K | — | 2025-09-12 | — | |
| S-1/A | — | 2025-09-08 | — | |
| S-1 | — | 2025-08-22 | — |
Showing 1–29 of 29 filings